Global capsule endoscopy market is expected to experience lucrative growth over the forecast period due to, the rising prevalence of gastrointestinal diseases, colorectal cancer, demand for faster and accurate diagnostics tools, and the presence of supportive government initiatives. Capsule endoscopy provides painless visualization of GI (gastrointestinal) tract images, transmitted via data recorder. Additionally, the introduction of technologically advanced capsules such as longer battery life and WiFi enabled are expected to further drive the growth of the capsule endoscopy market. The global capsule endoscopy market was valued at USD 454.7 million in 2014 and is expected to grow at a CAGR of 8.7% over the forecast period.
Increasing global geriatric population base is further expected to provide this market with a strong growth platform over the next seven years. Aging increases the risk of GI disorders such as CRC, inflammatory bowel disease, and appendicitis. According to the W.H.O, global population base pertaining to the age group – 65 years and above is expected to rise from 7% in 2000 to 16% in 2050. This is expected to significantly improve the patient base, thereby, driving the growth of the capsule endoscopy market.
Global capsule endoscopy market, by product, 2012 - 2022 (USD Million)
The capsule endoscopy market is analyzed by segmenting the market into small bowel capsule, esophageal capsule, and colon capsule. As of 2014, small bowel capsule held the largest market share, owing to its increasing usage in multiple medical conditions such as small bowel neoplastic lesions, inflammatory bowel disease, suspected Crohn’s disease and obscure GI tract bleeding. On the other hand, colon capsule segment is expected to register lucrative market growth over the forecast period. As stated by the CDC, every year colorectal cancer causes nearly 608,000 fatalities globally and over 14.5 million colonoscopies are performed. Additionally, growing demand for less invasive diagnosis platform are some key factors supporting the aforementioned conclusion.
Wireless capsule was the leading application segment of the capsule endoscopy market in 2014. The increasing usage rate of wireless capsules in the small intestine, esophagus and colon and the presence of favorable reimbursement policies are some high impact rendering drivers of the wireless capsule endoscopy market. Technologically advanced capsules with inbuilt features such as 360-degree panoramic view, greater battery life, enhanced data storage capability, easy transmission and larger frame rate are expected to provide the wireless capsule market with lucrative future growth opportunities.
Obscure gastrointestinal bleeding (OGIB) was one of the leading application segments of the capsule endoscopy market in 2014. According to a research study conducted by the U.S. National Library of Medicine, capsule endoscopy was found to be more effective than barium X-rays used for investigation of OGIB. Capsule endoscopy is widely used for diagnosis of occult bleeding in the duodenum as well as the diagnosis of Crohn’s disease and small bowel tumors. Additionally, owing to the advantages attached such as real-time visualization of the entire small intestine and faster & easier diagnosis, healthcare professionals, and patients are shifting their preference from conventional methods such double balloon enteroscopy to capsule endoscopy, which is expected to provide substantial growth platform to this market segment in near future. Crohn’s disease application market being in sync with the OGIB segment is expected to experience growth due to increasing prevalence rate of target disease coupled with adoption as preferred diagnosis method.
North America was the largest regional market in 2014. The rising prevalence rate of GI disorders & colorectal cancer coupled with advanced healthcare infrastructure, the presence of favorable reimbursement policies and increasing adoption of minimally invasive capsule endoscopy by patients are some factors expected to drive regional market growth over the forecast period. On the other hand, Asia-Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing patient awareness levels, disposable income, improving healthcare infrastructure and large presence of untapped opportunities with respect to cancer screening.
Key players of this market include Given Imaging, Olympus Corporation, IntroMedic Co., Ltd., Chongqing Jinshan Science & Technology (Group) Co., Ltd, Fujifilm Holding Corporation, CapsoVision and RF System lab. New product development aimed at widening application base is identified as one of the most viable sustainability strategies adopted by the manufacturers of capsule endoscopy devices. Additionally, the use of magnetic & hybrid capsules enabling better control and enhanced imaging are few other ongoing research attributes, expected to propel market growth and intensify competition during the forecast period.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.